Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal Imaging Biomarkers of Disease Progression in DLB
NCT03582488Phase 4Enrolling by invitation
- Start
- Jun 2018
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial. Primary endpoint: Rate of change in 18F-Flortaucipir PET imaging and Pittsburgh compound-B PET imaging. Started Jun 2018; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT03582488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582488.